ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

In Brief: Florida Osteopaths Join Medical Examiners, Nullify State’s Law Supporting Laetrile

January 18, 1985

UICC Grant Programs Available To Support International Activities

April 16, 1976

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014